/noncommunicable-diseases-rehabilitation-and-disability-(ncd)/office-of-the-director-ncd-(odn)/ncds-knowledge-action-portal.jpg?sfvrsn=d75056b8_4 "NCDs knowledge action portal")
Knowledge Action Portal on NCDs
Take a look behind the scenes of the Knowledge Action Portal (KAP).
Noncommunicable Diseases, Rehabilitation and Disability
We are responsible for leading, coordinating and monitoring global action to cover additional people with health services, medicines, vaccines, diagnostic and health technologies for the prevention, screening, early diagnosis and appropriate treatment of cardiovascular diseases, cancers, chronic respiratory diseases and diabetes. We aim to advance health equity for persons with disabilities, we have a focus on sensory impairments and bring together the work on rehabilitation from across the departments and from the 3 levels of the organization.
NCD data portal
Explore the data by country
On the road to 2025 and beyond
/noncommunicable-diseases-rehabilitation-and-disability-(ncd)/office-of-the-director-ncd-(odn)/on-the-road-to-2025-countdown-days.jpg?sfvrsn=7d7b21e4_79 "On the road to 2025 countdown days")
HLM4: On the road to 2025 and beyond
Preparatory process for the Fourth High-level Meeting of the UN General Assembly on the prevention and control of NCDs (HLM4)
/noncommunicable-diseases-rehabilitation-and-disability-(ncd)/office-of-the-director-ncd-(odn)/un-general-assembly-meeting-room.jpg?sfvrsn=b07fcc1d_7 "UN General Assembly meeting room")
Implementation roadmap 2023–2030
for the Global action plan for the prevention and control of NCDs 2013–2030
Related links
Related events and news
New publication
Related publications and documents
Other departmental work
Related health topics
Noncommunicable diseases
Jonathan Torgovnik
©
Credits
Cervical cancer
Cervical cancer
Cervical cancer develops in a woman's cervix (the entrance to the uterus from the vagina). Its primary cause is the infection with high-risk human papillomaviruses (HPV). Cervical cancer is caused by sexually acquired infection with certain types of human papillomavirus (HPV).
Technical links
Sensory functions, disability and rehabilitation
Risk factors
Other related health topics
Latest publications
All →
5 June 2025
Noncommunicable diseases progress monitor 2025
The fifth in a series, the World Health Organization's 2025 Noncommunicable Diseases (NCD) Progress Monitor provides a snapshot of country progress toward...
18 November 2024
Target product profiles for human papillomavirus screening tests to detect cervical pre-cancer and cancer
This document aims to set out the criteria for nucleic acid tests (NATs) to align with human papillomavirus (HPV) screening guidelines to detect cervical...
5 June 2024
WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention:...
In 2022, cervical cancer was the fourth most commonly occurring cancer among women globally and also the fourth leading cause of cancer deaths among...
8 March 2024
Meeting of the Director-General’s Expert Group on cervical cancer elimination: 25–26 September 2023
Key themes were raised by members of the Director-General’s Expert Group on cervical cancer elimination (CCEI) following technical updates on...
8 December 2020
WHO framework for strengthening and scaling-up services for the management of invasive cervical cancer
This document brings a new focus to the management of invasive disease in the comprehensive control and eventual elimination of cervical cancer. Aligned...
16 February 2019
Improving data for decision-making: a toolkit for cervical cancer prevention and control programmes
This publication, Improving data for decision-making: a toolkit for cervical cancer prevention and control programmes, expands the support provided...
3 January 2016
Mobile Health for Cervical Cancer (mCervicalCancer)
Digital health and technology can play an important role in supporting ongoing efforts to heighten the prevention, control and management of cervical cancer....
Feature stories
Fact sheets
Related links
Engagement with the private sector
Noncommunicable diseases and COVID-19